ZA879754B - Method of inhibiting interleukin-1 activity - Google Patents

Method of inhibiting interleukin-1 activity

Info

Publication number
ZA879754B
ZA879754B ZA879754A ZA879754A ZA879754B ZA 879754 B ZA879754 B ZA 879754B ZA 879754 A ZA879754 A ZA 879754A ZA 879754 A ZA879754 A ZA 879754A ZA 879754 B ZA879754 B ZA 879754B
Authority
ZA
South Africa
Prior art keywords
activity
inhibiting interleukin
interleukin
inhibiting
alleviation
Prior art date
Application number
ZA879754A
Other languages
English (en)
Inventor
Gerald L Mandell
L Mandell Gerald
Gail W Sullivan
W Sullivan Gail
William J Novick Jr
J Novick William Jr
Original Assignee
Hoechst Roussel Pharma
Univ Virginia Alumni Patent Fo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma, Univ Virginia Alumni Patent Fo filed Critical Hoechst Roussel Pharma
Publication of ZA879754B publication Critical patent/ZA879754B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA879754A 1986-12-31 1987-12-30 Method of inhibiting interleukin-1 activity ZA879754B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94790586A 1986-12-31 1986-12-31

Publications (1)

Publication Number Publication Date
ZA879754B true ZA879754B (en) 1989-07-26

Family

ID=25486973

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA879754A ZA879754B (en) 1986-12-31 1987-12-30 Method of inhibiting interleukin-1 activity

Country Status (14)

Country Link
EP (1) EP0279079B1 (ko)
JP (1) JP2507012B2 (ko)
KR (1) KR960015726B1 (ko)
AT (1) ATE151290T1 (ko)
AU (1) AU668982B2 (ko)
CA (1) CA1313137C (ko)
DE (1) DE3752048T2 (ko)
DK (1) DK482088A (ko)
ES (1) ES2103255T3 (ko)
GR (1) GR3024054T3 (ko)
IE (1) IE873554L (ko)
IL (7) IL106861A (ko)
WO (1) WO1988004928A1 (ko)
ZA (1) ZA879754B (ko)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5272153A (en) * 1986-12-31 1993-12-21 Hoechst-Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5196429A (en) * 1986-12-31 1993-03-23 Hoechst-Roussel Pharmaceuticals Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5196430A (en) * 1986-12-31 1993-03-23 Hoechst-Roussel Pharmaceuticals Inc. Method of inhibiting the activity of leukocyte derived cytokines
US4965271A (en) * 1986-12-31 1990-10-23 Hoechst Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
JPH04506215A (ja) * 1989-06-13 1992-10-29 スミスクライン・ビーチャム・コーポレイション モノカイン活性干渉
DD298051A5 (de) * 1989-08-16 1992-02-06 ��@���������@�������k�� Verfahren zur herstellung eines therapeutischen agens zur behandlung von verdauungskrankheiten
US6420374B1 (en) 1990-11-30 2002-07-16 Fred Hutchinson Cancer Research Center Use of xanthines as immunosuppressants and to inhibit allograft reactions
IL100195A0 (en) * 1990-11-30 1992-08-18 Hoechst Roussel Pharma Use of xanthines for the preparation of a medicament having immuno suppressing activity
IL100194A0 (en) * 1990-11-30 1992-08-18 Hoechst Roussel Pharma Use of xanthines for the preparation of a medicament effective for inhibiting the effects of allograft reaction in humans
JP3566719B2 (ja) * 1991-05-24 2004-09-15 フレッド ハッチンソン キャンサー リサーチ センター 外来性刺激に対する細胞性応答の調整
EP0518263A1 (en) * 1991-06-10 1992-12-16 Hoechst-Roussel Pharmaceuticals Incorporated Micropellets and a process for their manufacture
WO1993003728A1 (en) * 1991-08-27 1993-03-04 Temple University Of The Commonwealth System Of Xanthine suppression of antigen activation of t- or b-cells
JP3623501B2 (ja) * 1991-10-31 2005-02-23 ザ ビクトリア ユニバーシティ オブ マンチェスター インターロイキン−１阻害化合物による神経病学的状態の治療
WO1996005836A2 (en) * 1994-08-25 1996-02-29 Medical University Of South Carolina Methods of treating cold symptoms using pentoxifylline
US5856330A (en) * 1996-07-31 1999-01-05 Hoechst Aktiengesellschaft Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin
US5981536A (en) * 1996-07-31 1999-11-09 Hoechst Aktiengesellschaft Use of xanthine derivatives for the modulation of apoptosis
JP3830115B2 (ja) * 1997-10-06 2006-10-04 シャープ株式会社 液晶表示素子
TW561297B (en) * 1997-11-25 2003-11-11 Toshiba Corp Electrode wiring board subjected to counter measure against static electricity and display device using the same
JP3019053B2 (ja) * 1997-12-25 2000-03-13 日本電気株式会社 液晶表示装置及びその製造方法
US20090239886A1 (en) 2008-02-29 2009-09-24 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
US20110053961A1 (en) 2009-02-27 2011-03-03 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
JP2013503883A (ja) 2009-09-02 2013-02-04 コンサート ファーマシューティカルズ インコーポレイテッド 置換キサンチン誘導体
EP2611807A2 (en) 2010-09-01 2013-07-10 Concert Pharmaceuticals Inc. Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3-7-dimethyl-1h-purine-2,6(3h,7h)dione
WO2013013052A1 (en) 2011-07-19 2013-01-24 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
IN2014DN08443A (ko) 2012-04-13 2015-05-08 Concert Pharmaceuticals Inc
WO2013159006A1 (en) 2012-04-20 2013-10-24 Concert Pharmaceuticals, Inc. Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3,7-dimethyl-1h-purine-2,6(3h,7h)-dione

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2967632D1 (en) * 1978-04-22 1986-12-04 Beecham Wuelfing Gmbh & Co Kg Use of a xanthine derivate in the manufacture of a medicament
US4567183A (en) * 1983-03-11 1986-01-28 Analgesic Associates Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
GB8418430D0 (en) * 1984-07-19 1984-08-22 Beecham Wuelfing Gmbh & Co Kg Treatment

Also Published As

Publication number Publication date
CA1313137C (en) 1993-01-26
IE873554L (en) 1988-06-30
DE3752048D1 (de) 1997-05-15
IL100535A (en) 1994-05-30
EP0279079A2 (en) 1988-08-24
KR890700347A (ko) 1989-04-24
GR3024054T3 (en) 1997-10-31
DK482088A (da) 1988-10-28
EP0279079A3 (en) 1990-06-13
AU4602793A (en) 1993-11-18
IL100533A (en) 1994-05-30
AU1150588A (en) 1988-07-27
AU619732B2 (en) 1992-02-06
IL106859A (en) 1996-10-16
IL106854A (en) 1996-05-14
IL84934A (en) 1994-08-26
JPH02501829A (ja) 1990-06-21
IL100536A (en) 1994-05-30
AU668982B2 (en) 1996-05-23
JP2507012B2 (ja) 1996-06-12
ATE151290T1 (de) 1997-04-15
IL106861A (en) 1997-02-18
AU637542B2 (en) 1993-05-27
DK482088D0 (da) 1988-08-30
EP0279079B1 (en) 1997-04-09
AU1291892A (en) 1992-05-14
ES2103255T3 (es) 1997-09-16
WO1988004928A1 (en) 1988-07-14
KR960015726B1 (ko) 1996-11-20
DE3752048T2 (de) 1997-10-02

Similar Documents

Publication Publication Date Title
ZA879754B (en) Method of inhibiting interleukin-1 activity
TR23030A (tr) Asillendirilmis diketonik bilesiklerin ueretilmesine mahsus usul
IT8547927A0 (it) Composizione farmaceutica contenente un composto beta-bloccante per la profilassi ed il trattamento di disordini cardiaci
GB2182651B (en) Root zone plant for the purification of contaminated water
ZA878055B (en) A therapeutically useful compound
ATE86960T1 (de) Cyclopropanderivate.
GB8526344D0 (en) Supervising functioning of i c engine
PT80713A (en) Aryl derivatives of heterobicyclic compounds
IT1183061B (it) Composti dotati di attivita'antiallergica
FR2576577B1 (fr) Plate-forme semi-submersible de production petroliere, de stockage et de chargement en eau profonde
IT1181659B (it) Procedimento per l'elaborazione di segnali modem
IL75430A (en) Pineapple ketone carbonate derivatives and their use as flavoring agents
GR3004345T3 (ko)
ZA854841B (en) Aryl derivatives of heterobicyclic compounds
IT8823156A0 (it) Impianto per la depurazione meccanico-biologica di acque di rifiuto
IT1175808B (it) Procedimento per la preparazione di composto con attivita' antiulcera
GB8522174D0 (en) Production of oxygenated organic compounds
IE872207L (en) Inhibition of interleukin-1 production
IT8622389A0 (it) Procedimento per la preparazione di composti ad attivita' anti ulcera
KR890001929U (ko) 수심에 따라 자동 조절되는 낚시찌
IT1173244B (it) Procedimento per preparare il 7-(alfa-solfofenilacetamido)-3-(4'-carbamoilpiridinio)metil-3-cefem-4-carbossilato
KR860005495U (ko) 관상어용 여과판의 산소공급관
BR8504247A (pt) Bacia sanitaria acoplada a valvula de descarga
KR890001889U (ko) 콩나물 재배상의 용수 분배판
GB8421648D0 (en) Optimizing effectiveness of grip of screw &c